A panelist discusses how adjunctive therapies in Parkinson disease optimize and sustain dopamine levels in the central nervous system through various mechanisms of action that complement levodopa therapy.
Targeting the Dopaminergic Pathway: Evolving Approaches in Parkinson Disease
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines
2
Fenfluramine Treatment Leads to Long-Term Improved Everyday Executive Functioning in Lennox-Gastaut Syndrome
3
NeurologyLive®: Charting our 2026 Conference Coverage
4
FDA Action Update, December 2025: Acceptance, Approval, and Clearance
5